Status:

COMPLETED

The Effect of Personal Protective Aids on Hypertension and Diabetes in People Exposed to High Levels of Air Pollution

Lead Sponsor:

Medstar Health Research Institute

Collaborating Sponsors:

Indian Institute of Technology Kanpur

Conditions:

Pollution; Exposure

HTN

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This is a randomized controlled trial to evaluate personal protective aids (air purifier and N95) as a therapeutic measure in people with hypertension and diabetes exposed to high levels of PM2.5 in I...

Detailed Description

Air pollution is the largest environmental cause of disease and premature death in the world today, disproportionally affecting low- and middle-income countries (LMICs) such as India. Numerous studies...

Eligibility Criteria

Inclusion

  • Hypertension arm
  • Individuals age 18-70 years old with systolic blood pressure between 130-160 mmHg, regardless of medication use
  • Stable hypertension for the past 3 months with no medication changes
  • No planned medication changes for the duration of the study
  • Exposure to outdoor air pollution above a certain threshold (pollution levels will be measured using AirVeda devices)
  • Individuals who sleep in a closed space (such as a bedroom) for minimum of 6 hours/daily.
  • Use of gas (LPG)/electricity for cooking purposes
  • Diabetes arm
  • Individuals age 18-70 years old with fasting blood glucose between 126-180 mg/dL, regardless of medication use
  • Stable diabetes for the past 3 months with no medication changes
  • No planned medication changes for the duration of the study
  • Exposure to outdoor air pollution above a certain threshold (pollution levels will be measured using AirVeda devices)
  • Individuals who sleep in a closed space (such as a bedroom) for minimum of 6 hours/daily.
  • Use of gas (LPG)/electricity for cooking purposes

Exclusion

  • Unwilling to participate
  • Unstable blood pressure and/or blood glucose level requiring frequent medication changes
  • Individual suffering from a physical or mental illness that precludes active study participation
  • Current smoker
  • Planned vacation/absence from the study site
  • Patients with life expectancy \< 12 months
  • Pregnant patients

Key Trial Info

Start Date :

March 25 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 17 2024

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT04854187

Start Date

March 25 2021

End Date

October 17 2024

Last Update

October 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sehat Charitable trust

Dalkhola, West Bengal, India, 733201